Stuttgart (ots) – On the occasion of World Hypertension Day on May 17, 2023, experts from the Society for Biofactors e. V. (GfB) pointed out the antihypertensive effect of magnesium.
In Germany, almost two-thirds of people aged 65 and older suffer from high blood pressure – with fatal consequences. Hypertension increases the risk of heart disease and stroke.
Diuretic diuretics are considered standard in the treatment of high blood pressure. They withdraw water from the body and in this way reduce the pressure in the vessels. However, important minerals, especially magnesium, are also lost with the liquid. A vicious circle, since the biofactor magnesium plays an important role in the performance of the heart muscle. As a natural calcium antagonist, magnesium has a vasodilating and blood pressure-lowering effect, it can normalize the heart rate and protect heart muscle tissue. Conversely, a magnesium deficiency can promote neuromuscular excitability, which increases the risk of high blood pressure, cardiac insufficiency and cardiac arrhythmias.
“Numerous studies show that magnesium substitution has a positive influence on high blood pressure. The studies show a lowering effect on both systolic and diastolic blood pressure,” emphasizes Prof. Dr. medical Klaus Kisters, internist and one of the GfB’s scientific experts.
Magnesium: positive for high blood pressure and cardiac insufficiency
When taking supplements, it should be taken into account that organic magnesium compounds are generally better tolerated than inorganic compounds and are characterized by higher bioavailability. “Scientific studies show that oral therapy with magnesium orotate increases both life expectancy and quality of life in patients with high blood pressure and cardiac insufficiency,” says Dr. Kisters.
Conclusion? A magnesium deficiency in high blood pressure must be avoided urgently in order to reduce further consequential damage and improve the quality of life.
The Society for Biofactors e. V. is a non-profit association that aims to promote the scientific basis of therapy and prophylaxis with biofactors (www.gf-biofaktor.de).
Press contact:
dr Daniela Birkelbach www.gf-biofaktor.de 0171/8548226 [email protected]
Original content from: Society for Biofactors, transmitted by news aktuell
Press portal newsroom: news up-to-date GmbH